Hyposwiss Advisors’s Colgate-Palmolive CL Stock Holding History

Hyposwiss Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-555	Closed	-$47.3K	–	107
2026 Q1	$47.3K	Hold	555	–	–	0.05%	93
2025 Q4	$43.9K	Buy	+555	New	+$43.5K	0.04%	92

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hyposwiss Advisors's CL Position: Q2 2026 in Review

Hyposwiss Advisors sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 555 shares — an estimated $47.3K sold.

Hyposwiss Advisors first reported a position in CL in Q4 2025 and held it in 2 quarters. The position peaked at $47.3K in Q1 2026. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Hyposwiss Advisors reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
Hyposwiss Advisors sold 555 Colgate-Palmolive shares in Q2 2026, an estimated $47.3K.
Hyposwiss Advisors first reported a position in Colgate-Palmolive in Q4 2025 and held it in 2 quarters.
Hyposwiss Advisors's Colgate-Palmolive position peaked at $47.3K in Q1 2026.
2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hyposwiss Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.